{"disease":{"id":"va-ecmo","name":"va ecmo"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05730894","title":"Predictors of Mortality in Patients With VA-Extracorporeal Membrane Oxygenation.","phase":"","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"Hamad Medical Corporation","has_results":false},{"nct_id":"NCT03323268","title":"Use of Exhaled Carbon Dioxyde for Monitoring the Native Cardiac Function During Mechanical Circulatory Support With Venoarterial By-pass in Intensive Care Unit","phase":"","overall_status":"COMPLETED","enrollment_count":39,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT07141524","title":"Optimizing Breathing and Blood Flow in Patients Treated With VA ECMO","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":10,"lead_sponsor_name":"Beth Israel Deaconess Medical Center","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}